$25.82
+0.30 (+1.18%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+409.3% upside
Low Target
$82.08
Average Target
$131.49
High Target
$141.61
Current Price
$25.82
Current
$25.82
$25.82
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Scenario Analysis
Bear Case
$82.08
217.9%
Low target
Base Case
$131.49
+409.3%
Avg target
Bull Case
$141.61
+448.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$27.65
-6.6% from high
52-Week Low
$8.67
+198.0% from low
50-Day SMA
$22.49
+14.8% vs SMA
200-Day SMA
$14.32
+80.3% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$131.49
+375.6% vs high
Next Earnings Report
Aug 19, 2026
10d
until earnings
EPS Est: $-0.53
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |